Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Rocket Pharmaceuticals Inc (RCKT)

Rocket Pharmaceuticals Inc (RCKT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Rocket Pharmaceuticals Inc 9 Cedarbrook Drive Cranbury NJ 08512 USA

www.rocketpharma.com Employees: 299 P: 609-659-8001

Sector:

Medical

Description:

Rocket Pharmaceuticals, Inc. is an emerging, clinical-stage biotechnology company. It focused on developing first-in-class gene therapy treatment options for rare, undertreated diseases. Rocket Pharmaceuticals Inc., formerly known as Inotek Pharmaceuticals Corporation, is based in LEXINGTON, United States.

Key Statistics

Overview:

Market Capitalization, $K 370,119
Enterprise Value, $K 206,479
Shares Outstanding, K 108,222
Annual Sales, $ 0 K
Annual Net Income, $ -258,750 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -50,330 K
EBIT, $ -250,480 K
EBITDA, $ -241,100 K
60-Month Beta 0.66
% of Insider Shareholders 24.76%
% of Institutional Shareholders 98.39%
Float, K 81,426
% Float 75.24%
Short Volume Ratio 0.34

Growth:

1-Year Return -74.14%
3-Year Return -82.00%
5-Year Return -94.26%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -72.78%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.45 on 11/06/25
Next Earnings Date N/A
Earnings Per Share ttm -2.22
EPS Growth vs. Prev Qtr 23.73%
EPS Growth vs. Prev Year 36.62%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-4 on 01/05/18

RCKT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -61.54%
Return-on-Assets % -53.13%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.06
Book Value/Share 2.91
Interest Coverage -135.90
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar